Clinical Trial: Expression of EPK in Recurrent Miscarriage

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: MAP Kinase Signaling Pathways Through ERK and p-ERK Protein in Human Placenta of Women With Recurrent Miscarriage

Brief Summary: The present study is based on hypotheses that some as yet unknown genetic factors may result in recurrent miscarriage (RM). Consequently, the main aim of this study was to gain new information about the underlying genetic causes of RM in the Egyptian population and to investigate the expression of ERK and p-ERK protein in human placenta and their corresponding tissue, to assess the significance of MAPK signal pathway in progression of recurrent miscarriage and PI3K-Akt Pathway.

Detailed Summary:
Sponsor: Assiut University

Current Primary Outcome: The levels of ERK and AKT in placenta [ Time Frame: 48 hours ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Assiut University

Dates:
Date Received: February 24, 2016
Date Started: January 2015
Date Completion:
Last Updated: February 26, 2016
Last Verified: February 2016